The invention will allow surgeons to give patients synthetic heart valves that free them to live lives indistinguishable from ...

With restored circulation, the TAH allowed Harbison to regain enough strength within 10 days to also undergo a heart ...

Advancements in medical technology have made it possible to replace heart valves using the TAVI (Transcatheter Aortic Valve ...

Scientists at Queen Mary University of London are developing a newly invented material for creating artificial heart valves as effective as native ...

For years, it was shrouded in secrecy. It was heart surgery’s Manhattan Project, whispered to be set to change the world. And ...

Anticoagulant therapy in untreated patients with emboli reduced the incidence of subsequent thromboembolism. Hemorrhagic complications occurred in 23 patients (8%); one died. Thromboembolism is a ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heart valve disease -- aortic stenosis (AS).

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Background Valvular heart disease (VHD) represents a significant burden on healthcare systems worldwide, necessitating ...

Edoxaban was at least as effective as warfarin in preventing thromboembolism after bioprosthetic valve replacement in the ...

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic ...